David Zeiler: For biotech stock investors, what happened to Aquanox Pharmaceuticals Inc. (NASDAQ:AQXP) over the past week looked like the ultimate fantasy come true.After reporting positive results from a mid-stage test for its bladder pain syndrome/interstitial cystitis drug AQX-1125 on Aug. 7, Aquanox stock took off like a rocket.Have you ever wondered how billionaires continue to get RICHER, while the rest of the world is struggling?“I study […]
Epizyme (NASDAQ:EPZM)On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed this drug to treat these NHL […]
Avalanche Biotech (NASDAQ:AAVL)Shares of Avalanche Biotech fell as much as 40% in after-hours trading on June 15, 2015 after the company announced results from its phase 2 wet-age related macular degeneration — wet-AMD — trial. The drop is huge but many investors should be assured that the drop was justified because the results were mediocre at best. In addition if […]
Kyle Anderson: Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.That’s why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.Have you ever wondered how billionaires continue to get RICHER, while the rest of […]
Immunogen (NASDAQ:IMGN)Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy treatments such as platinum and paclitaxel […]
View gallery.This week brings to close yet another year of gains for the stock market, the sixth straight year in this bull run.The benchmark S&P 500 started off 2014 at 1848 and as of Friday the index sat at 2088.Some of the top industries of the year include airlines, semiconductors, hospitals, aluminum, Internet service providers and residential REITs.Another industry cracking this […]
It isn’t a surprise to most that the biotech names have had a rough start to the year.
Really, March was pretty bad.
However, with the market recovering as of late, many of the beaten up biotech stocks have rebounded somewhat. A lot of analysts believe the rebound will continue.
As an investor, if you agree with those analysts, then it certainly wouldn’t […]